The case for optimising operations in medical device manufacturing

With the injectable drug delivery device market predicted to grow from $39.93 billion in 2022 to $43.54 billion in 2023, 60% of drugs in the R&D pipeline designed for injectable deliveryii, and patients increasingly administering their own medication wherever possible, drug delivery device…

Source: www.medicalplasticsnews.com – Read more